Citgroup on Monday said it is selling the last of its business operations in Russia, and expecting to log a $1.1 billion loss in the proces...

Citigroup has agreed to sell its China consumer wealth portfolio, including clients, assets under management, and deposits, to HSBC. The de...

Germany's largest bank said in a note dated June 9 and viewed by Reuters that it had uncovered a shortfall in the shares that back the depo...

The group had announced plans in April 2021 to exit its Chinese consumer banking business as part of a global strategy to withdraw from con...

Berkshire also finally exited Wells Fargo & Co, a 33-year-old investment that Buffett soured on after finding it too slow to address revela...

Russia has not defaulted on its foreign debts since the Bolshevik Revolution in 1917, when the collapse of the Russian Empire led to the cr...

Depositary receipts are certificates issued by a bank representing shares in a foreign company traded on a local stock exchange. They allow...

There is a growing realisation that these sanctions are likely to remain long-term, industry sources told Reuters, which means strategic no...

So far, Asia’s commodity and shipping stocks are emerging as safer bets given concerns about shortages of raw materials as Russia is a majo...

While inflows into exchange-traded funds have driven gold’s advance in 2020, buying by central banks has helped underpin bullion in recent ...

Ambit Capital has maintained buy rating on Sudarshan Chemicals with a target price of Rs 420.

The outlook comes as the Opec and its allies send mixed supply signals to the market.

Different brokerages, came out with these recommendations this week in separate notes to their clients.

nce many large Russian companies are controlled by the state or by billionaires with close ties to President Vladimir Putin, even narrowly ...

Stagnant revenue, job cuts and pressure to shrink quickly and curb compensation have weighed down banks based in London, Zurich and New Yor...

Citigroup recommends 'Hold' rating on Dr Reddy’s Laboratories with a target price of Rs 547.

The lights may be going out on Wall Street, where for the first time since World War II bankers are on the verge of earning less from initi...